Pharmaceutical

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology...

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology

VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company")...

THX Pharma, Biocodex and the Beyond Batten Disease Foundation Stand Together with the CLN3 Batten Community on International Batten Disease Awareness Day

The three partners are proud to jointly serve as Platinum Sponsors of the 2026 BDSRA Annual Family Conference, where they...

SmithRx Launches Best-in-Class Partner Ecosystem to Help Employers Deliver Sustainable and Clinically Appropriate GLP-1 Programs at Scale

SmithRx partners with 9amHealth, Calibrate, Cost Plus Drugs, FlyteHealth, Form Health, and others to deliver sustainable GLP-1 coverage, achieving up...

AllyGPO and BioCareSD Earn Gold Globee® Award for Pioneers for Disrupting Specialty Drug Group Purchasing and Distribution for Independent Oncology and Retina Practices

Partnership honored for reimagining legacy specialty drug purchasing and distribution models — equipping community-based practices with the transparency, technology, and...

error: Content is protected !!